Taking hematological tumors as an example, Köhrer found that in B-acute lymphoblastic leukemia, cell signaling activates the FOXO1 pathway and inhibits the occurrence and development of B-cell tumors, indicating that FOXO1 plays an anti-tumor role in B-ALL [27]. This evidence concerns the gene FOXO1 and precursor B-cell acute lymphoblastic leukemia.